SynAct Pharma publishes Annual Report 2023

SynAct Pharma AB (publ) (“SynAct”) today publishes the Annual Report for the financial year 2023. The Annual Report is attached to this press release and available on the company’s website

The annual report is published in Swedish and English. The Swedish annual report is also available on SynAct's website in European Single Electronic Format (ESEF).

For further information, please contact:

Jeppe Øvlesen
CEO SynAct Pharma
Tel: +45 2844 7567
Email: [email protected]

Björn Westberg
CFO SynAct Pharma
Email: [email protected]